Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sanguine
company
About
Sanguine develops innovative technology solutions for clinical researchers.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $224.98K
- Industries
- Apps,Biotechnology,Clinical Trials,Health Care,Life Science,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Sanguine develops innovative technology solutions for clinical researchers. The company facilitates clinical trials by recruiting participants, conducting at-home data collection, and processing samples, enabling clinicians to prescribe the right medicines.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$2.22M
Sanguine has raised a total of
$2.22M
in funding over 2 rounds. Their latest funding was raised on
Feb 26, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 26, 2019 | Grant | $224.98K | 1 |
National Science Foundation
|
— | Detail |
| Feb 23, 2013 | Seed | $2M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Sanguine is funded by 2 investors.
National Science Foundation
and Heliant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Heliant Ventures
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
